Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Thrivent Financial for Lutherans reduced its stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 33.0% in the fourth quarter, according to the company in its most recent 13F filing with ...

Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been given a consensus recommendation of “Moderate ...

In trading on Wednesday, shares of Denali Therapeutics Inc (Symbol: DNLI) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $13.86 per share.

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Denali Therapeutics (NASDAQ:DNLI) on Friday, setting a price... H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Denali ...

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's ...

Liquidia Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat ...

After hours: March 26 at 7:58:23 PM EDT Loading Chart for IRTC ...